RADL3 Stock Chart & Stats
$18.48
$0.23(1.26%)
―
--
Day’s Range― - ―
52-Week Range$13.25 - $27.42
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
R$32.30B
Enterprise Value$48.12K
Total Cash (Recent Filing)R$542.62M
Total Debt (Recent Filing)R$8.69B
Price to Earnings (P/E)24.1
Beta1.04
Next Earnings
Aug 04, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.77
Shares Outstanding1,752,367,300
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio3.61
Price to Book (P/B)5.27
Price to Sales (P/S)0.87
P/FCF Ratio37.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.89
Revenue Forecast (FY)R$46.93B
Raia Drogasil S.A. News
RADL3 FAQ
What was Raia Drogasil S.A.’s price range in the past 12 months?
Raia Drogasil S.A. lowest stock price was $13.25 and its highest was $27.42 in the past 12 months.
What is Raia Drogasil S.A.’s market cap?
Raia Drogasil S.A.’s market cap is R$32.30B.
When is Raia Drogasil S.A.’s upcoming earnings report date?
Raia Drogasil S.A.’s upcoming earnings report date is Aug 04, 2026 which is tomorrow.
How were Raia Drogasil S.A.’s earnings last quarter?
Raia Drogasil S.A. released its earnings results on May 05, 2026. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by -$0.01.
Is Raia Drogasil S.A. overvalued?
According to Wall Street analysts Raia Drogasil S.A.’s price is currently Undervalued.
Does Raia Drogasil S.A. pay dividends?
Raia Drogasil S.A. does not currently pay dividends.
What is Raia Drogasil S.A.’s EPS estimate?
Raia Drogasil S.A.’s EPS estimate is 0.24.
How many shares outstanding does Raia Drogasil S.A. have?
Raia Drogasil S.A. has 1,752,367,300 shares outstanding.
What happened to Raia Drogasil S.A.’s price movement after its last earnings report?
Raia Drogasil S.A. reported an EPS of $0.16 in its last earnings report, missing expectations of $0.17. Following the earnings report the stock price went down -1.848%.
Which hedge fund is a major shareholder of Raia Drogasil S.A.?
Currently, no hedge funds are holding shares in BR:RADL3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Raia Drogasil S.A.
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.
Technical Analysis
Bath & Body Works, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr0.25 Sh
―
Macy's, Inc. Unsponsored Brazilian Depository Receipt Repr 1/1 Sh
―
OdontoPrev S.A.
―
Sprouts Farmers Market, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.3333333 Sh
―
Natura Cosmeticos SA
―